Sergio Bernardini

About

Sergio Bernardini is a leading figure in laboratory medicine, whose work bridges cutting-edge analytical chemistry with the future of clinical diagnostics. His research focuses on emerging technologies in laboratory medicine, the development of advanced mass spectrometry methods, and the clinical application of biomarkers. Bernardini’s major contributions include pioneering a quantitative method for analyzing glycated and glutathionylated hemoglobin using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), a technique that has significantly improved the precision of diabetes and oxidative stress monitoring. This foundational work, published in 2004, has garnered 56 citations. More recently, he co-authored a landmark report for the IFCC-Emerging Technologies Division, "Key questions about the future of laboratory medicine in the next decade of the 21st century" (2019, 86 citations), which has become a guiding framework for the field, addressing challenges like automation, data integration, and personalized medicine. Bernardini’s impact is evident in his ability to shape both technical methodologies and strategic directions, making him a vital voice for students and researchers navigating the rapidly evolving landscape of clinical laboratory science.

Research Focus

Key Achievements

Top Papers

1. 1
   Key questions about the future of laboratory medicine in the next decade of the 21st century: A report from the IFCC-Emerging Technologies Division

   86 citations · 2019
2. 2
   A quantitative method for the analysis of glycated and glutathionylated hemoglobin by matrix-assisted laser desorption ionization-time of flight mass spectrometry

   56 citations · 2004

Key Collaborators

Contact & Links